External Nitric Oxide Measurement Through SNO Degradation
NCT04903535 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2026-02-09
Summary
In this study, we aim to explore the feasibility of a novel, noninvasive SNO assay to acquire physiological SNO quantification from various parts of the human body and test this new method of analysis. This study aims to help with the currently cumbersome and invasive procedures used to measure SNOs in the body. The proposed activities do not unnecessarily duplicate previous experiments.
Conditions
- Healthy
- Unconscious
Interventions
- DEVICE
-
Alonefire SV003 10W 365nm UV Flashlight
Investigator will use a Nitric Oxide Analyzer while attached to a small suction port on the subject's ear lobe to be tested for Nitric Oxide. After getting the baseline assay, the investigator will shine a low-intensity UV Flashlight (Alonefire SV003 10W 365nm UV Flashlight) at the ear lobe for 10 seconds, repeated three times at 20 second intervals, to determine if there is photobleaching. Then the assay will then be performed on the opposite ear lobe. Fifteen minutes after the third UV flashlight exposure, the investigator will collect air from the subject's ear during photolysis into a 20mL glass syringe (once from each ear). Fifteen minutes after the third UV flashlight exposure, the investigator will collect air from the subject's ear during photolysis into a 20mL glass syringe (once from each ear). The subject and the investigator will wear UV goggles during the experiment.
Sponsors & Collaborators
-
Indiana University
lead OTHER
Principal Investigators
-
Nadzeya Marozkina, PhD, MD · Indiana University School of Medicine
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Day
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-10
- Primary Completion
- 2026-12-30
- Completion
- 2026-12-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Arousal Analysis by Pulse Wave Amplitude in Patients With Obstructive Sleep Apnea
NCT01690429 ·Status: COMPLETED ·Phase: NA
-
NO Measurements in Screening for Asthma and OSA, in Patients With Severe Snoring
NCT03964324 ·Status: COMPLETED ·Phase: NA
-
Dim Light at Night in Patients With Obstructive Sleep Apnea
NCT01853891 ·Status: WITHDRAWN ·Phase: NA
-
Pilot Study of Negative Pressure Sleep Therapy System to Treat Obstructive Sleep Apnea
NCT02324790 ·Status: TERMINATED ·Phase: NA
-
The Effects of Nasal Airflow on Upper Airway Dilator Muscles During Sleep
NCT03506178 ·Status: UNKNOWN ·Phase: NA
-
Role of Heme-oxygenase (HO) and Nitric Oxide (NO) Pathway in Patients With Obstructive Sleep Apnea (OSA) and Pulmonary Hypertension (PH)
NCT02368171 ·Status: UNKNOWN
-
Data Collection Study to Review Novel Methods for Diagnosing Obstructive Sleep Apnea
NCT06930404 ·Status: RECRUITING
-
The Effect of Inspiratory Muscle Training on Cognitive Functions, Cerebral Oxygenation, and Neurotrophic Factor Level in Patients With Obstructive Sleep Apnea Syndrome
NCT07329049 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Postoperative Nasal High Flow Versus Oxygen for Positive Airway Pressure Non-Compliance Sleep Apnea Patients
NCT02485236 ·Status: COMPLETED ·Phase: NA
-
Sleep Apnea in Heart Failure With Preserved Ejection Fraction
NCT05008432 ·Status: COMPLETED
-
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
NCT05428839 ·Status: RECRUITING ·Phase: NA
-
Obstructive Sleep Apnea in the Absence of Metabolic Syndrome
NCT01635010 ·Status: COMPLETED ·Phase: PHASE4
-
Oxidative Stress and Endothelial Dysfunction in Obstructive Sleep Apnea
NCT00646971 ·Status: TERMINATED ·Phase: NA
-
Nocturnal Oxygen Treatment in Heart Failure and Cheyne-Stokes Respiration
NCT00338078 ·Status: COMPLETED ·Phase: NA
-
A Validation Study of the NightOwl Home Sleep Apnea Test
NCT04764734 ·Status: UNKNOWN ·Phase: NA
-
Long-term Effect of High Flow Nasal Canula Therapy on Obstructive Sleep Apnea
NCT05549310 ·Status: UNKNOWN ·Phase: NA
-
Prediction of Exacerbations and Management of COPD Patients With SAH Based on Millimeter Wave Radar Monitoring
NCT05019911 ·Status: UNKNOWN
-
The General Breathing Record Study
NCT03356288 ·Status: COMPLETED
-
Intermittent-Hypoxia Inhibits Neutrophil Extracellular Traps Formation: Role of Cathelicidins
NCT07129486 ·Status: NOT_YET_RECRUITING
-
Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index
NCT03062748 ·Status: ENROLLING_BY_INVITATION
-
Sleep Disordered Breathing in Children: Inflammation and Oxidative Stress
NCT02040701 ·Status: UNKNOWN
-
Validation of a Novel Device for Screening Patients With Symptoms of Obstructive Sleep Apnea
NCT04121923 ·Status: COMPLETED ·Phase: NA
-
Clinical Efficacy of High-flow Nasal Cannula Oxygen Therapy in Patients With Obstructive Sleep Apnea
NCT05549245 ·Status: UNKNOWN ·Phase: NA
-
SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS
NCT03288376 ·Status: COMPLETED
-
Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic Breathing
NCT00909259 ·Status: COMPLETED ·Phase: PHASE1